Sigyn Therapeutics SIGY
OTC SIGY
$0.04 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Sigyn Therapeutics (SIGY) Research & Development (2020 - 2025)

Updated

Sigyn Therapeutics (SIGY) reported Research & Development of $29,681 for Q3 2025, down 85.6% from $206,161 a year earlier but up 296.7% from the prior quarter.

Analysis

Sigyn Therapeutics (SIGY) Research & Development (2020 - 2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Sigyn Therapeutics' Research & Development came in at $140,101, down 84.3% year-over-year; for FY2024, it was $773,279, down 3.1% from FY2023.

  • Research & Development has a four-year compound annual growth rate of 16.5% (FY2020 to FY2024).
  • By year, Research & Development came in at $798,165 in FY2023 (+21.4%), $657,657 in FY2022 (-10.4%), $734,014 in FY2021 (+75.0%) and $419,362 in FY2020.
  • Five-year quarterly Research & Development spans a low of $7,482 in Q2 2025 and a high of $417,384 in Q4 2020.
  • Year over year, Research & Development has now declined in each of the last five quarters, with an average decline of 27.4% over the last eight quarters.
  • The high point for year-over-year Research & Development in five years was Q1 2022 (growth of 96.0%); the low point was Q2 2025 (a decline of 96.9%).
  • Per Business Quant data, the three quarters before Q3 2025 came in at $7,482 (Q2 2025), $8,842 (Q1 2025) and $94,096 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 892.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 370.60 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 771.00 Mn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 554.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 278.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 258.00 Mn
10 Sigyn Therapeutics 64,215.08 -46,853.92 - 29,681.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 29,681.00
Jun 30, 2025 7,482.00
Mar 31, 2025 8,842.00
Dec 31, 2024 94,096.00
Sep 30, 2024 206,161.00
Jun 30, 2024 240,429.00
Mar 31, 2024 232,593.00
Dec 31, 2023 215,933.00
Sep 30, 2023 215,230.00
Jun 30, 2023 219,159.00
Mar 31, 2023 147,843.00
Dec 31, 2022 140,861.00
Sep 30, 2022 133,770.00
Jun 30, 2022 154,683.00
Mar 31, 2022 228,342.00
Dec 31, 2021 250,259.00
Sep 30, 2021 227,503.00
Jun 30, 2021 139,736.00
Mar 31, 2021 116,516.00
Dec 31, 2020 417,384.00
API Access

Sigyn Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=SIGY&period=max&api_key=YOUR_API_KEY